Influenza Group A & B Viral Load Quantitative Test
Short Name: Influenza A/B Viral Load
Also known as: Flu A/B Viral Load, Influenza A/B PCR Quantitative, Respiratory Viral Panel (Influenza)
Influenza Group A & B Viral Load Quantitative Test test available at DNA Labs India for ₹5,950. Uses Real-Time PCR (RT-PCR) on Nasopharyngeal swab, throat swab, nasal aspirate, bronchial aspirate samples. Results in Reports are delivered within 3 working days after sample collection. Email reports available within 36 hours, phone reports within 24 hours.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Kothari Ramesh Shantilal
Consultant Microbiologist · Reg: 27670
Last reviewed: September 7, 2026
Overview
The purpose of this test is to detect and quantify the presence of Influenza A and B viruses in respiratory secretions. It aids in confirming influenza infection, differentiating between types A and B, and measuring viral load to monitor disease progression and treatment efficacy.
- Test Code
- 6164
- CPT Code
- 87502
- ICD Code
- J10.1
- Price
- ₹5,950
- Sample Type
- Nasopharyngeal swab, throat swab, nasal aspirate, bronchial aspirate
- Result Time
- Reports are delivered within 3 working days after sample collection. Email reports available within 36 hours, phone reports within 24 hours.
- Fasting Required
- No
- Method
- Real-Time PCR (RT-PCR)
Sample Collection
No special preparation required. Inform your healthcare provider about any medications you are taking, especially antiviral drugs.
Method: Swab from nasopharynx or throat
Laboratory Analysis
A healthcare professional will collect a swab from your nasopharynx or throat. You may experience mild discomfort, but the procedure is quick.
Report Delivery
No specific precautions. You can resume normal activities immediately.
Timeline: Reports are delivered within 3 working days after sample collection. Email reports available within 36 hours, phone reports within 24 hours.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to detect and quantify the presence of Influenza A and B viruses in respiratory secretions. It aids in confirming influenza infection, differentiating between types A and B, and measuring viral load to monitor disease progression and treatment efficacy.
How to Prepare
- Use sterile swabs and viral transport medium
- Collect sample within 3-5 days of symptom onset for best sensitivity
- Label sample properly with patient details
- Transport sample to laboratory at 2-8°C if delayed
Doctor's Notes
Reviewed by Dr Kothari Ramesh Shantilal — MBBS, MD (Microbiology) · Reg. No. 27670
"Quantitative viral load testing is crucial for managing severe influenza, especially in immunocompromised patients, as it helps monitor treatment response and disease progression."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Insufficient sample volume
- Improper labeling
- Sample in inappropriate transport medium
- Hemolyzed or contaminated samples
- Samples collected after 7 days of symptom onset
Understanding Your Results
Positive
Active Influenza A infection. Antiviral treatment may be considered.
Positive
Active Influenza B infection. Antiviral treatment may be considered.
Negative
No evidence of Influenza A or B infection. Other respiratory pathogens should be considered.
Consult a doctor immediately if you experience difficulty breathing, persistent high fever, chest pain, confusion, or worsening symptoms, especially if you are in a high-risk group.
Limitations
- ⚠A negative result does not rule out influenza if clinical suspicion is high
- ⚠Viral load may not correlate with disease severity in all patients
- ⚠Test detects RNA, not viable virus; infectivity not assessed
- ⚠Results should be interpreted in conjunction with clinical findings
Risks & Considerations
- ●Minimal risk of minor bleeding or discomfort at collection site
- ●Rare risk of fainting during sample collection
- ●No significant health risks associated with the test
Interfering Factors
- ●Improper sample collection or storage may lead to false negatives
- ●Recent antiviral therapy may reduce viral load
- ●Cross-contamination during sample processing
- ●Inhibitors in the sample (e.g., blood, mucus) can affect PCR
Compare With Similar Tests
| Test | Influenza Group A & B Viral Load Quantitative Test | Rapid Antigen Test | Viral Culture | Qualitative RT-PCR |
|---|---|---|---|---|
| Comparison | Influenza Group A & B Viral Load Quantitative Test |
Frequently Asked Questions
What is the cost of the Influenza A & B Viral Load Quantitative Test?
How is the sample collected for this test?
Do I need to fast before the test?
How long does it take to get results?
What is the difference between Influenza A and B?
Can this test detect COVID-19?
Is home sample collection available?
What does 'viral load' mean?
Who should get this test?
Are there any risks associated with the test?
Can I take antiviral medication before the test?
How accurate is this test?
Related Tests
FCGR2B Gene Malaria, resistance to NGS Genetic Test
₹20,000ICAM1 Gene Malaria, cerebral, susceptibility to NGS Genetic Test
₹20,000ITS Sequencing
₹5,600IL12RB2 Gene Atypical Mycobacterial infection, IL12RB2 related NGS Genetic Test
₹20,000Parvovirus B19 Qualitative PCR Test
₹5,000Respiratory Panel 5 Test
₹4,500Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.